Journey Medical Corp (DERM)
3.40
-0.14
(-3.95%)
USD |
NASDAQ |
Apr 24, 16:00
3.43
+0.03
(+0.88%)
After-Hours: 20:00
Journey Medical Profit Margin (Quarterly): -14.05% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -14.05% |
| September 30, 2023 | 48.61% |
| June 30, 2023 | -48.70% |
| March 31, 2023 | -82.99% |
| December 31, 2022 | -66.65% |
| September 30, 2022 | -62.55% |
| June 30, 2022 | -41.16% |
| March 31, 2022 | -5.92% |
| Date | Value |
|---|---|
| December 31, 2021 | -124.2% |
| September 30, 2021 | -54.29% |
| June 30, 2021 | -77.61% |
| March 31, 2021 | 2.50% |
| December 31, 2020 | 18.23% |
| September 30, 2020 | 0.31% |
| June 30, 2020 | 4.83% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-124.2%
Minimum
Dec 2021
48.61%
Maximum
Sep 2023
-33.57%
Average
-41.16%
Median
Jun 2022
Profit Margin (Quarterly) Benchmarks
| Fortress Biotech Inc | -46.52% |
| Puma Biotechnology Inc | 17.00% |
| GT Biopharma Inc | -- |
| FibroGen Inc | -207.2% |
| Outlook Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -30.97% |
| Return on Assets | -4.66% |
| Return on Invested Capital | -14.55% |
| Gross Profit Margin (Quarterly) | 60.58% |
| Operating Margin (Quarterly) | -13.79% |
| Return on Net Operating Assets | -7.03% |